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Abstract
Background: Methyl mercury (MeHg), an important environmental toxicant is implicated in neurological disorders
such as Hunter-Russell syndrome and Autism. Therefore, the present work is in search of new drugs that can
alleviate MeHg toxicity. In this connection, Tagara, an ayurvedic drug is used for assessing its neuro protective effect
against MeHg toxicity.
Methods: In the present study, we assessed the phytochemical contents of Tagara by colorimetric and HPLC
analyses. The neuroprotective effect of Tagara on MeHg induced neurotoxicity was measured in terms of viability
by MTT assay and oxidative stress in terms of catalase activity, glutathione and thiobarbituric acid reactive
substance levels. Further, the chelating effect of Tagara towards MeHg was performed to identify the molecular
mechanism. Statistical analysis was done by statistical package for social sciences (SPSS) version 16.0.
Results: The results demonstrated that Tagara contains significant amounts of phenols and flavonoids. Also, HPLC
analysis of Tagara revealed the presence of essential oils such as hydroxyvalerenic and valerenic acids. Our results
demonstrated that exposure of rat brain mitochondrial fractions to MeHg resulted in a dose dependent death in
MTT assay and IC50 value was found to be 10 μM. However, a 250 μg dose of Tagara effectively prevented MeHg
induced mitochondrial damage. The oxidative stress caused by MeHg results in elevated levels of reactive oxygen
species as evidenced by elevated TBARS (Thiobarbituric acid-reactive substances) levels and diminished catalase
enzyme activity and glutathione content. However, Tagara at 250 μg concentration offsets these alterations caused
by MeHg. Further, Tagara also diminished GSH oxidation caused by MeHg, confirming its chelating effect, one of
the molecular mechanisms that triggers protection against oxidative damage.
Conclusion: Our results revealed that MeHg induced toxicity is predominantly mediated through oxidative stress
mechanism and the propensity of Tagara to abolish such reactions. Hence, we propose that Tagara with a source of
potential neuroprotectants may be a useful approach to alleviate MeHg associated neurotoxicity.
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Background
Mercury is one of the potential environmental xeno-
biotic toxicants that is implicated in long-term neuro-
logical and developmental disorders in both animals and
humans [1, 2]. Among different forms of mercury, MeHg
(organic form) is an important neurotoxicant due to its
higher entry rate into the CNS compared with inorganic
mercurials [3, 4]. Human exposure to methylmercury
(MeHg) through consumption of sea foods results in aut-
ism spectrum disorders, Alzheimer’s disease, Parkinson’s
disease, Huntington’s disease, Minamata disease epilepsy,
depression, mood disorders and tremor [4–8].
Current focus of research in the neurotoxicology field is
to identify the underlying mechanism behind mercury-
induced neurotoxicity and also to find out the antidotes to
counteract the toxic effects. Among the three important
molecular mechanisms of MeHg-induced neurotoxicity
such as oxidative stress, disruption of calcium homeostasis
and impairment of glutamate homeostasis, evidences
pointed out that oxidative stress, particularly in mitochon-
dria is a central mechanism [6, 8].
Though there are researches related to development of
drugs, the treatment for neurological disorders remains
wretched due to failure of regeneration of central nervous
tissues by modern drugs and their adverse side effects. Be-
cause oxidative stress is a common phenomenon in metal
toxicity, it is important to understand the interaction be-
tween antioxidants and neurotoxicants such as methyl
mercury. The benefits associated with intake of antioxi-
dants have been attributed mainly to the antioxidant
activity of medicinal plants. Also, some of the Ayurvedic
herbs such as Acorus calamus, Nardostachys jatamansi,
Herpestis monniera etc., are effective in the treatment of
most of the neurological disorders [9].
In this regard, Tagara (Valeriana wallichii of family
Valerianaceae), an ayurvedic drug that possesses protective
effects on several aspects of brain and nervous conditions
is chosen for the present study. It is well used in various
pharmaceutical preparations for the treatment of migraine
[10, 11] , insomnia and anxiety [12]. Tagara is also reported
to have antioxidant effect [13]. Although studies have docu-
mented the various pharmacological activities of Tagara,
very little is known about its interaction with MeHg in-
duced neurotoxicity. Therefore, the intention of the present
study is to find out the therapeutic response of Tagara, an
ayurvedic drug against methyl mercury induced neurotox-
icity. The antioxidants such as phenols and flavonoids
present in Tagara were assessed by colorimetric method
and the presence of essential oils was confirmed through
HPLC. The cell viability was assessed by MTT assay and
catalase, glutathione and TBARS levels were also assessed.
Also, the chelating effect of Tagara towards MeHg is per-
formed that revealed the molecular mechanism of action of
Tagara against MeHg induced oxidative stress.
Methods
Animals
Adult Wistar rats (9 months old) were bred in the animal
house of Vellore Institute of Technology. All the experi-
mental procedures were carried out in accordance with
committee for the purpose of control and supervision of
experiments on animal (CPCSEA) guidelines, and all ex-
periments were approved by the institutional animal eth-
ics committee (VIT/IAEC/VII/14). The animals were
maintained at 23 °C on a 12 h light/dark cycle with free
access to water and food (VIT University, Vellore, India).
Chemicals
Methylmercury (II) chloride, 5, 5′-dithiobis-(2- nitro ben-
zoic acid) (DTNB), glutathione (GSH)-reduced form and
3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium
bromide (MTT) were purchased from Sigma. All other
chemicals used were of analytical grade.
Plant sample preparation
Tagara, a whole plant powder in the form of capsules
was procured from Himalaya Company, Bangalore,
India. Tagara powder of 1 mg/ml concentration was pre-
pared and was determined for total phenolic and flavon-
oid contents.
Total phenolic content
The amount of total phenolics present in Tagara was de-
termined using Folin-Ciocalteau (FC) reagent as described
using gallic acid as standard [14]. To different concentra-
tions of Tagara, FC and sodium carbonate were added and
incubated at room temperature for 20 min. Then, the ab-
sorbance was measured at 730 nm. Values are represented
as mean ± S.E (n = 3).
Total flavonoid content
The amount of total flavonoids present in Tagara was
determined using quercetin as standard [15]. To differ-
ent concentrations of Tagara, potassium acetate and alu-
minium nitrate were added. After 40 min of incubation
at room temperature, the absorbance was measured at
415 nm. Values are represented as mean ± S.E (n = 3).
Sample preparation for HPLC analysis
For HPLCanalysis, 2 g of fine powder of Tagara was
weighed and transferred to a 100 mL volumetric flask. It
was then diluted to volume with methanol: water (80:20)
and sonicated for 30 min. Then, it was filtered through a
0.45 μm membrane filter [16].
HPLC instrumentation
HPLC experiments were performed on a YungLin HPLC
system equipped with Phenomenex Luna C18, 5 mm
(4.6 × 250 mm) column, LC10AT VP pumps, SCL-10AVP
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system controller, SIL-10 AD VP auto injector, SPD-M10
AVP photodiode array detector and class VP software was
used [16].
Analytical method for HPLC analysis
In this method, the mobile phase used was a mixture of
methanol and 0.5 % phosphoric acid (80:20). The follow-
ing parameters were set such as flow rate of 1.5 ml/min,
column temperature of 30 °C and detection wave length
at 225 nm. The injection volume used was 20 μl and the
total run time was 15 min. The chromatographic system
was equilibrated by the mobile phase. [16].
Sample preparation for neuro protective property
Mitochondrial enriched fractions were prepared essen-
tially as described by Franco et al. [17]. Reaction mixture
(R1) of 150 μL was prepared by incubating 2 mg of mito-
chondrial enriched protein with different concentrations
of MeHg (0, 5, 10, 25, 50, 75 and 100 μM) and of Tagara
(10, 25, 50, 100, 250 and 500 μg) in a medium containing
5 mM HEPES buffer (pH 7.0), 110 mM mannitol, 34 mM
sucrose, and 5 mM KCl for 30 min at 25 °C. After incuba-
tions, following parameters were assessed.
Total protein
Protein concentration was determined by using Lowry
method [18].
MTT assay
Mitochondrial function was assessed by MTT assay [19].
The reaction mixture (R1) of 150 μL was incubated with
150 μL of 1.2 mM MTT for 30 min at 25 °C. The purple
formazan crystal pellets were dissolved in DMSO, and
the colour obtained was measured at 550 nm. The re-
sults were expressed as percentage viability.
Glutathione content
Glutathione content was measured by the method of
Ellman [20]. The reaction mixture (R1) of 150 μL was in-
cubated with 600 μL of 10 % trichloroacetic acid. Then it
was centrifuged at 4000 rpm for 10 min at 4 °C. To the
supernatant, 300 μL of Ellman’s reagent and 600 μL of
0.1 M phosphate buffer were added. The yellow color de-
veloped was read at 412 nm.
TBARS levels
Lipid peroxidation levels were measured as thiobarbitu-
ric acid reactive substances (TBARS) according to the
method of Ohkawa [21]. To 150 μL of reaction mixture
(R1), 0.375 % 2-thiobarbituric acid, 5 % trichloroacetic
acid and 0.25 N HCl were added and was incubated at
95 °C for 60 min. Then the tubes were centrifuged at
1000 rpm for 10 min, and the pink color developed was
estimated at 535 nm.
Catalase assay
Catalase enzyme was measured according to the method
described by Sinha [22]. To 150 μL of reaction mixture
(R1), 1.35 ml of 0.01 M phosphate buffer (PH 7.0) and
600 μL of 0.2 M hydrogen peroxide were added. After 30 s,
3 ml of dichromate acetic acid mixture (1:3) were added
and then heated in a boiling water bath for 10 min. The
green color developed was read at 620 nm.
Chelating effect
The chelating effects of Tagara towards MeHg were ana-
lyzed by an indirect method. 10 μM concentration of
MeHg was incubated with GSH (100 μM) in the presence
or absence of Tagara (250 μg) at 25 °C for 30 min. Then
the amount of reduced form of GSH was determined by
reaction with 5, 5′-dithiobis-(2-nitrobenzoic acid) that in-
directly gives the measure of free mercury [20].
Statistical analysis
Statistical differences among groups were analyzed by
one-way analysis of variance followed by Duncan’s mul-
tiple range tests when required. Pearson analysis was
used to correlate variables. Differences were considered
statistically significant when P < 0.05.
Results
Total phenol content (TPC)
Phenolics play a vital role in the free-radical scavenging
properties of plants. The total phenolic content in
Tagara was found to be 185 mg of Gallic acid equiva-
lents per gram of Tagara (Table 1). (Standard curve
equation: y = 0.069×, r2 = 0.992).
Total flavonoid content (TFC)
The total flavonoid content found in Tagara was found to
be 110 mg of Quercetin equivalents per gram of Tagara
(Table 1). (Standard curve equation: y = 0.139×, r2 = 0.998).
Table 1 Total phenolic and total flavanoid contents of Tagara
Name TPC (mg of GAE/g of extract) TFC (mg of Quercetin
equivalents/g of extract)
Tagara 185 ± 0.07 110 ± 0.4











3.56 3.60 Roy, 1999
2 Valerenic acid 11.15 11.31
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HPLC analysis
The presence of essential oils at 225 nm by HPLC was
determined in Tagara and compared with published data
[16]. By comparing the retention times of the standards,
following compounds (Table 2, Fig. 1) were identified in
Tagara viz, (hydroxyvalerenic acid and valerenic acid).
Assessment of mitochondrial viability
In MTT assay, our results indicated that MeHg de-
creased the mitochondrial activity in a dose-dependent
manner (Fig. 2) and IC50 value was found to be 10 μM.
However, Tagara at 250 μg concentrations and positive
control quercetin at 250 μM restore MeHg induced
mitochondrial dysfunction (Fig. 3).
Protective effect of Tagara against MeHg induced
oxidative stress
The glutathione level was found to be reduced signifi-
cantly to 51 % (P < 0.05) when MeHg was used (Fig. 4).
However, Tagara at 10 μg concentration and quercetin at
10 μM concentration have completely prevented this re-
duction in glutathione levels.
The activity of catalase was significantly reduced in
MeHg intoxicated group vs. the control group by
−49 % (P < 0.05). After treatment with Tagara and
positive control quercetin, there is a significant im-
provement in the catalase activity viz, +39 and +45 %,
respectively (Fig. 5).
The TBARS levels are significantly increased in the
MeHg treated group compared with the control group
Fig. 1 HPLC Chromatogram of Tagara. 1. Hydroxyvalerenic acid, 2. Valerenic acid
Fig. 2 Influence of MeHg on mitochondrial function. Data are expressed as viability percentage. Values are represented as mean ± standard
error. *indicates statistically different from control (P < 0.05)
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by +128 %. After administration of Tagara and positive
control quercetin, a significant reduction (P < 0.05) was
noted compared with the control by +8 and +14 %, re-
spectively (Fig. 6).
Chelating effect
In order to investigate the chelating effect of Tagara
against MeHg, the amount of “free” mercurial in the
reaction medium was indirectly measured by using re-
duced glutathione content. Table 3 shows that Tagara
at 250 μg concentration was effective in chelating
MeHg. The presence of Tagara in the reaction medium
changed the oxidative capability of MeHg that con-
verts reduced glutathione to oxidized form.
Discussion
Many heavy metals including mercury have the ability to
produce ROS which initiate chain reactions that provoke
oxidation of biomolecules such as lipids, proteins and nu-
cleic acids [23]. Antioxidants defend against metal toxicity
by trapping free radicals and or by chelating metal ions
[24]. Therefore, the antioxidants such as total phenolics
and flavonoids present in Tagara are estimated in the
present study. Our study showed that there is a significant
amount of phenolics and flavonoids in Tagara, which are
thought to be the potential neuro protectants and thus can
be used in the treatment of oxidative stress related neuro-
logical diseases.
In addition, the essential oils are also reported to have
neuro protective properties. The HPLC results of our
Fig. 3 Neuroprotective property of Tagara against MeHg-induced mitochondrial dysfunction. Data are expressed as percentage of viability. Values
are represented as mean ± standard error. *indicates statistically different from control (P < 0.05)
Fig. 4 Glutathione contents in treated and untreated groups with Tagara. Data are expressed as percentage of control. Values are represented as
mean ± standard error. *indicates statistically different from control (P < 0.05)
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study also substantiate the presence of essential oils such
as hydroxyvalerenic acid and valerenic acid in Tagara.
Previous reports also indicated that the roots and rhi-
zomes are highly aromatic and contain valerenic acid
that has been shown to inhibit the breakdown of neuro
transmitter gamma-aminobutyric acid (GABA) that re-
sults in sedation [25].
To study the neuroprotective property of Tagara, iso-
lated rat brain mitochondria a major target for MeHg in-
duced oxidative stress was used as a model [26]. ROS
which are produced as a result of normal oxygen metab-
olism at higher concentration are important mediators
of oxidative stress and cell damage [27]. Our results also
showed that oxidative stress, induced by MeHg results
in significant reduction in mitochondrial function. Previ-
ous reports also suggested the same [10, 26].
However, the deleterious effects of ROS are counterba-
lanced by both antioxidant enzymes such as catalase, super-
oxide dismutase and non-enzymatic antioxidants such as
glutathione, vitamins, flavonoids, phenolics etc. [24].
Excessive free radicals play an important role in neural dis-
orders and therefore medicinal plants with rich sources of an-
tioxidants are given considerable importance as they are the
important scavengers of free radicals. Many reports suggested
that neuroprotective mechanism of bioflavonoids is partly re-
lated to their metal chelating and antioxidant properties [28].
Plants also contain important therapeutic metabolites that are
involved in brain cell regeneration. Previous study also
Fig. 5 Catalase activity in treated and untreated groups with Tagara. Data are expressed as percentage of control. Values are represented as
mean ± standard error. *indicates statistically different from control (P < 0.05)
Fig. 6 TBARS levels in treated and untreated groups with Tagara. Data are expressed as percentage of control. Values are represented as mean ± standard
error. *indicates statistically different from control (P< 0.05)
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confirms that the bioactive compound turmerone in turmeric
increases neural stem cell growth in the brain and helps in dif-
ferentiation of neural stem cells to neurons [29].
Therefore in our study, we sought Tagara, an important
medicinal herb is responsible for protection against MeHg
induced neurotoxicity, using mitochondrial enriched rat
brain fractions. Our results showed that MeHg induced
oxidative stress results in mitochondrial damage by de-
creasing the defense mechanisms such as reduced gluta-
thione (GSH) content and catalase enzyme levels. This
GSH depletion is due to the fact that MeHg interferes
with the uptake of cystine, which is a precursor of GSH
synthesis [30, 31] and its interaction with GSH as it has
high affinity with SH-groups of GSH [32, 33]. The protect-
ive effects of GSH are related to its antioxidant capacity
and its ability to conjugate with MeHg for its efflux [34]
and therefore its depletion results in cell damage and
neurotoxicity. It is interesting to note that there is an in-
crease in GSH content by Tagara (250 μg concentration),
supposed to be a promising neuroprotective agent against
MeHg-induced neurotoxicity.
Reports also suggested that, catalase an enzyme that
detoxifies hydrogen peroxide are reduced in response
with MeHg whereas, Tagara efficiently restored catalase
activiy. This is in accordance with our previous study
with Brahmi [35]. Hence, we could presume that the
elevation of GSH and catalase enzyme could be one of
the major mechanisms by which Tagara counteracts
MeHg toxicity.
It is suggested that oxidative injury, especially lipid per-
oxidation, via a powerful oxidant (e.g., hydroxyl radicals),
may play an important role in cerebellar degeneration
during MeHg intoxication. In the present study, our re-
sults indicated that MeHg increased the levels of thiobar-
bituric acid reactive substances (TBARS), a marker of
lipid peroxidation. It has been previously reported that the
elevation of TBARS is due to an oxidative injury by
hydroxyl radicals [36]. Although the levels of TBARS were
enhanced in MeHg induced neurotoxicity, Tagara
decreased these levels in a significant manner.
In addition to the antioxidant properties of Tagara,
the ability to chelate mercurial ions represents an
important mechanism for neuroprotection. In fact, our
results showed that (Table 3) Tagara is able to chelate
metal ions and reinforce its therapeutic potential against
MeHg intoxication.
Conclusion
The data reported here strengthens the antioxidant and
protective proficiency of Tagara against MeHg neuro-
toxicity. Considering the facts that oxidative stress
has been implicated in MeHg toxicity and medicinal
plants are effective in counteracting the toxic effects of
MeHg, the use of Tagara may represent an important
therapeutic approach. The present study shows that
GSH oxidation is a critical phenomenon involved with
MeHg induced mitochondrial dysfunction and that the
protective effect of Tagara on such process is directly
related to its chelating effect. The phytochemical and
HPLC analyses showed the presence of phenols and fla-
vonoids, as well as essential oils. These results indicated
that Tagara exerts a significant protection against
MeHg induced in vitro neurotoxicity. However, these
issues need further investigations on the molecular
mechanisms associated with mercurial toxicity and the
pharmacological studies of Tagara with respect to mer-
curial poisoning through cell lines and in vivo studies.
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